PATENT CLAIM ANALYSIS

Application Number: 15893861
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["424", "682000"]

Abstract:
The present invention provides, among other things, compositions and methods suitable for the treatment of hyperphosphatemia based on phosphate-binding magnesium salts. In some embodiments, the present invention provides compositions and methods suitable for the treatment of hyperphosphatemia based on the combination of phosphate-binding magnesium and calcium salts.

Claim (Index 119):
The method of  claim 117 , wherein the enteric coating comprises one or more of acetyltributyl citrate, carbomers, cellulose acetate phthalate, cellulose acetate succinate, ethyl cellulose, guar gum, hypromellose acetate succinate, hypromellose phthalate, polymethacrylates, polyvinyl acetate phthalate, shellac, tributyl citrate, triethyl citrate, white wax or zein.

Metadata:
- Claim Count in Document: 71.0
- Percentile: 88.0
- Lexical Diversity: 1.85714
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15477325', '15155366', '12422012', '13445771', '13856084']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.773734190566086
- 35 USC 102 Novelty (BERT): 0.5643402678968903
- Combined Prediction Score: 0.7527947982991665
- Mean Citation Score: 413.804244
- Max Citation Score: 436.84155
- Similarity Product: 359.7793391643942

Labels:
- Claim Label 101: 0
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 0

Dataset: test